Activest Wealth Management Invests $32,000 in VanEck Pharmaceutical ETF (NASDAQ:PPH)

Activest Wealth Management acquired a new stake in VanEck Pharmaceutical ETF (NASDAQ:PPH) in the fourth quarter, HoldingsChannel.com reports. The fund acquired 373 shares of the company’s stock, valued at approximately $32,000.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management lifted its holdings in shares of VanEck Pharmaceutical ETF by 117.4% in the 4th quarter. Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management now owns 200,000 shares of the company’s stock valued at $17,256,000 after buying an additional 108,000 shares during the period. Mirae Asset Global Investments Co. Ltd. raised its position in VanEck Pharmaceutical ETF by 51.3% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 248,473 shares of the company’s stock worth $23,565,000 after acquiring an additional 84,273 shares in the last quarter. Adamsbrown Wealth Consultants LLC raised its position in VanEck Pharmaceutical ETF by 102.3% in the fourth quarter. Adamsbrown Wealth Consultants LLC now owns 149,631 shares of the company’s stock worth $12,910,000 after acquiring an additional 75,659 shares in the last quarter. Thrivent Financial for Lutherans boosted its position in shares of VanEck Pharmaceutical ETF by 33.6% during the 3rd quarter. Thrivent Financial for Lutherans now owns 234,890 shares of the company’s stock worth $22,322,000 after purchasing an additional 59,025 shares in the last quarter. Finally, Miller Investment Management LP boosted its position in shares of VanEck Pharmaceutical ETF by 13.4% during the 3rd quarter. Miller Investment Management LP now owns 207,535 shares of the company’s stock worth $19,722,000 after purchasing an additional 24,446 shares in the last quarter.

VanEck Pharmaceutical ETF Stock Down 0.4 %

Shares of PPH opened at $89.40 on Monday. VanEck Pharmaceutical ETF has a 52-week low of $84.48 and a 52-week high of $99.51. The company has a 50-day simple moving average of $87.76 and a 200-day simple moving average of $91.72. The company has a market capitalization of $557.86 million, a PE ratio of 21.04 and a beta of 0.72.

VanEck Pharmaceutical ETF Increases Dividend

The business also recently announced a dividend, which was paid on Monday, December 30th. Shareholders of record on Friday, December 27th were issued a $0.411 dividend. The ex-dividend date was Friday, December 27th. This is a boost from VanEck Pharmaceutical ETF’s previous dividend of $0.36.

VanEck Pharmaceutical ETF Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.